Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing StandardBusiness Wire · Oct 9, 2026
New Strong Sell Stocks for October 9thZacks Investment Research · Oct 9, 2026
New Strong Sell Stocks for October 6thZacks Investment Research · Oct 6, 2026
Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company's Next Chapter of GrowthGuruFocus · Sep 17, 2026
Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company's Next Chapter of GrowthBusiness Wire · Sep 17, 2026
BlackRock Inc. Acquires New Stake in Accendra Health, Inc. $ACHDefense World · Sep 4, 2026Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 10, 2026 | -$0.08 | -$0.19 | Miss |
| May 11, 2026 | -$0.06 | -$0.04 | Beat |
| Feb 19, 2026 | $0.22 | $0.21 | Miss |
| Oct 30, 2025 | $0.23 | $0.25 | Beat |
| Aug 11, 2025 | $0.27 | $0.26 | Miss |
| May 8, 2025 | $0.20 | $0.23 | Beat |